ChiCTR2300067491 版本V1.2 版本创建时间2023/07/02 14:41:41 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300067491 

最近更新日期:

Date of Last Refreshed on:

2023-05-13 00:49:26 

注册时间:

Date of Registration:

2023-01-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

6岁以下小儿单肺通气方式的比较

Public title:

Comparison of one lung ventilation modes in children under 6 years old

注册题目简写:

English Acronym:

研究课题的正式科学名称:

6岁以下小儿单肺通气方式的比较

Scientific title:

Comparison of one lung ventilation modes in children under 6 years old

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘国亮 

研究负责人:

刘国亮 

Applicant:

liu guoliang 

Study leader:

liu guoliang 

申请注册联系人电话:

Applicant telephone:

13810120027

研究负责人电话:

Study leader's telephone:

13810120027

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liuguoliang0@163.com

研究负责人电子邮件:

Study leader's E-mail:

liuguoliang0@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区南礼士路56号

研究负责人通讯地址:

北京市西城区南礼士路56号

Applicant address:

No. 56, Nanli Shi Road, Xicheng District, Beijing

Study leader's address:

No. 56, Nanli Shi Road, Xicheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京儿童医院

Applicant's institution:

Beijing Children’s Hospital, Capital Medical University

研究负责人所在单位:

首都医科大学附属北京儿童医院

Affiliation of the Leader:

Beijing Children’s Hospital, Capital Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2022]-E-236-Y

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京儿童医院医学伦理委员会

Name of the ethic committee:

Ethical Committee of Beijing Children’s Hospital, Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-23 00:00:00

伦理委员会联系人:

郭永丽

Contact Name of the ethic committee:

Guo yongli

伦理委员会联系地址:

首都医科大学附属北京儿童医院医学伦理委员会

Contact Address of the ethic committee:

Ethical Committee of Beijing Children’s Hospital, Capital Medical University

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 59616083

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

首都医科大学附属北京儿童医院

Primary sponsor:

Beijing Children’s Hospital, Capital Medical University

研究实施负责(组长)单位地址:

首都医科大学附属北京儿童医院

Primary sponsor's address:

Beijing Children’s Hospital, Capital Medical University

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京儿童医院

具体地址:

北京市西城区南礼士路56号

Institution
hospital:

Beijing Children’s Hospital, Capital Medical University

Address:

No. 56, Nanli Shi Road, Xicheng District, Beijing

经费或物资来源:

Source(s) of funding:

none

Target disease:

Mediastinal tumor

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

对比支气管内插管和支气管内封堵两种单肺通气方式在6岁以下儿童的应用效果  

Objectives of Study:

To compare the effects of endobronchial intubation and endobronchial occlusion in children under 6 years old

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

入选标准:1.0<年龄≤6岁 2.ASAⅠ~Ⅱ级 3.拟行胸腔镜手术患儿 4.近期无呼吸道感染 5.气道无畸形 6.无严重循环神经系统性疾病 7.签署知情同意书

Inclusion criteria

inclusion criteria: 1.0< Age: ≤6 years old 2.ASA I ~ Ⅱ grade 3. 4 patients with thoracoscopic surgery. No recent respiratory tract infection 5. No airway malformations 6. No severe circulatory neurosystemic disease 7. Sign informed consent

排除标准:

排除标准:1.体重指数>30kg/m2 2.术前吸入空气低血氧<95% 3.对已知麻醉药物过敏患儿

Exclusion criteria:

Exclusion criteria: 1. Body mass index > 30kg/m2 2. Preoperative inhalation of air hypoxia < 95% 3. Children allergic to known narcotic drugs

研究实施时间:

Study execute time:

From 2023-01-01 00:00:00 To 2023-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-01-10 00:00:00 To 2023-06-30 00:00:00  

干预措施:

Interventions:

组别:

A组

样本量:

28

Group:

Group A

Sample size:

干预措施:

支气管内插管单肺通气

干预措施代码:

Intervention:

Endobronchial intubation with one lung ventilation

Intervention code:

组别:

B组

样本量:

28

Group:

Group B

Sample size:

干预措施:

支气管内封堵单肺通气

干预措施代码:

Intervention:

Intrbronchial occlusive single lung ventilation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

首都医科大学附属北京儿童医院 

单位级别:

三甲 

Institution
hospital:

Beijing Children’s Hospital, Capital Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肺萎陷评分

指标类型:

主要指标

Outcome:

Lung collapse score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 6 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

数字随机代码方法进行随机化。

Randomization Procedure (please state who generates the random number sequence and by what method):

Numerical random code method for randomization.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-01-10 09:48:40